26-A-17995-ACC CLINICAL OUTCOMES OF SGLT2 INHIBITOR USE IN HEART FAILURE WITH END-STAGE RENAL DISEASE: A PROPENSITY-MATCHED TRINETX ANALYSIS
Ricardo Estrada Mendizabal(University of Alabama at Birmingham Hospital), Rosy Thachil(Elmhurst Hospital Center), Mohamed Bassiony(Elmhurst Hospital Center), Colin Carpenter(Elmhurst Hospital Center), Omar W Aboukhatwa(University of Alabama at Birmingham Hospital), Rocio Barriga Guzman(Elmhurst Hospital Center), Juan Rodriguez-Riascos(Elmhurst Hospital Center), Leonel Al Dakar(University of Alabama at Birmingham Hospital), Dimitrios Bampatsias(University of Alabama at Birmingham Hospital), Anureet Malhotra(Elmhurst Hospital Center), Abdelmajid Al Jariri(Elmhurst Hospital Center), Alena Gonzalez(University of Alabama at Birmingham Hospital), Ariela Baur(Elmhurst Hospital Center), Samantha Lo(University Health Network)
Cited by 0
Related Papers
Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta-analysis
|JNCI Journal of the National Cancer Institute|2023|79
Pathologically Proven Papillary Fibroelastomas Attached to the Left Atrial Appendage and Pulmonary Vein Ridge
|JACC Case Reports|2025|2
Left Atrial Papillary Fibroelastoma Mimicking Myxoma
|JACC Case Reports|2025|1
Microplastics and Cardiovascular Disease: Should Clinicians Be Paying Attention?
|Current Cardiology Reports|2025|1